www.fdanews.com/articles/204709-fda-grants-eua-to-acon-laboratories-home-covid-19-test
FDA Grants EUA To Acon Laboratories’ Home COVID-19 Test
October 6, 2021
The FDA has issued an emergency use authorization to San Diego, Calif.-based Acon Laboratories’ Flowflex COVID-19 Home Test, an over-the-counter antigen test.
By the end of 2021, the company plans to produce more than 100 million tests per month, increasing to 200 million per month by February 2022.
The authorization “is expected to double rapid at-home testing capacity in the U.S. over the next several weeks,” the agency said.